Arcadia Biosciences (RKDA) Profit After Tax (2014 - 2025)

Arcadia Biosciences' Profit After Tax history runs 12 years deep, the most recent figure standing at -$1.3 million for Q4 2025.

• Quarterly Profit After Tax rose 66.91% year-over-year to -$1.3 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$2.3 million (up 59.62% YoY) and the FY2025 annual result came in at -$2.3 million, up 45.82% from the prior year.
• Profit After Tax was -$1.3 million for Q4 2025 at Arcadia Biosciences, down from $856000.0 in the prior quarter.
• Across five years, Profit After Tax topped out at $144.0 million in Q2 2021 and bottomed at -$9.4 million in Q1 2023.
• A 5-year average of $5.4 million and a median of -$2.3 million in 2021 frame the typical range for Profit After Tax.
• Annual changes were most pronounced in 2021 — Profit After Tax jumped 1555.57% — and 2022, when it slumped 374.24%.
• Arcadia Biosciences' Profit After Tax stood at -$7.5 million in 2021, then soared by 43.41% to -$4.2 million in 2022, then jumped by 236.76% to $5.8 million in 2023, then tumbled by 169.56% to -$4.0 million in 2024, then soared by 66.91% to -$1.3 million in 2025.
• Business Quant data shows RKDA's Profit After Tax at -$1.3 million in Q4 2025, $856000.0 in Q3 2025, and -$4.5 million in Q2 2025.